Consolidated Statement of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (81,730)	$ (71,935)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,033	980
Amortization of Intangible Assets	8,132	0
Amortization of investments	(148)	(353)
Amortization of debt issuance costs	1,111	727
Stock-based compensation	9,394	8,638
Loss on extinguishment of debt	(1,223)	0
Loss on disposal of property and equipment	236	0
Change in fair value of warrants	(1,746)	(91)
Change in fair value of contingent value rights	7,569	0
Changes in operating assets and liabilities
Trade accounts receivable	10,062	6,686
Prepaid expenses and other current assets	2,758	386
Inventory	1,960	5,144
Accounts payable	(5,008)	1,173
Other accrued liabilities	(12,135)	4,650
Accrued trade discounts and rebates	4,280	798
Accrued returns reserve	3,277	272
Deferred rent	(238)	0
Increase (Decrease) In Supply Agreement Liabilities	(5,280)	0
Other	(2,258)	62
Net cash used in operating activities	(86,772)	(66,589)
Cash flows from investing activities
Capital expenditures	(392)	(954)
Payments to Acquire Investments	0	(30,784)
Sales and maturities of investments	25,685	93,100
Net cash used in investing activities	25,293	61,362
Cash flows from financing activities
Proceeds from equity offerings	30,000	27,000
Payments of equity offering costs	0	54
Proceeds from issuance of debt	97,295	0
Repayments of Long-term Debt	(43,496)	0
Payments of debt issuance costs	4,816	0
Payments for loss on extinguishment of debt	(737)	0
Proceeds from issuance of employee stock purchase plan shares	510	374
Proceeds from exercise of stock awards	8	167
Repurchase of common stock withheld for taxes	447	365
Net cash provided by financing activities	78,317	27,122
Effect of exchange rate on cash and cash equivalents	0	(1)
Increase (decrease) in cash and cash equivalents	16,838	21,894
Cash and cash equivalents, beginning of period	67,271	37,598
Cash and cash equivalents, end of period	84,109	59,492
Supplemental schedule of cash flow information
Cash paid for interest	7,689	5,350
Supplemental schedule of non-cash investing and financing activities
Issuance Of Warrants For Loan Agreement	$ 2,080	$ 0